These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 9141488)

  • 1. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Denatured proteins as cofactors for plasminogen activation.
    Machovich R; Owen WG
    Arch Biochem Biophys; 1997 Aug; 344(2):343-9. PubMed ID: 9264548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The fibrinolytic system: A new target for treatment of depression with psychedelics.
    Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
    Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Role of Fibrinolytic System in Health and Disease.
    Kwaan HC
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of heparin with plasminogen activators and plasminogen: effects on the activation of plasminogen.
    Andrade-Gordon P; Strickland S
    Biochemistry; 1986 Jul; 25(14):4033-40. PubMed ID: 2943315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced fibrinolysis by proteolysed coagulation factor Xa.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2010 Apr; 1804(4):723-30. PubMed ID: 19931652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma fibronectin enhances fibrinolytic system in vitro.
    Gilboa N; Kaplan JE
    Thromb Haemost; 1985 Oct; 54(3):639-44. PubMed ID: 2935966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA.
    Nishino T; Yamauchi T; Horie M; Nagumo T; Suzuki H
    Thromb Res; 2000 Sep; 99(6):623-34. PubMed ID: 10974349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of kringles derived from human plasminogen on fibrinolysis in vitro.
    Sugiyama N; Iwamoto M; Abiko Y
    Thromb Res; 1987 Aug; 47(4):459-68. PubMed ID: 2821651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation and interactions in the activation of cell-associated plasminogen.
    Myöhänen H; Vaheri A
    Cell Mol Life Sci; 2004 Nov; 61(22):2840-58. PubMed ID: 15558213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. uPA-mediated plasminogen activation is enhanced by polyphosphate.
    Whyte CS; Mutch NJ
    Haematologica; 2021 Feb; 106(2):522-531. PubMed ID: 32029503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An elastase-dependent pathway of plasminogen activation.
    Machovich R; Owen WG
    Biochemistry; 1989 May; 28(10):4517-22. PubMed ID: 2504279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasminogen-plasmin fibrinolytic system accelerates degradation of alginate-poly-L-lysine-alginate microcapsules in vitro.
    Hsu BR; Fu SH; Tsai JS; Huang YY; Huang HS; Chang KS
    Transplant Proc; 1997 May; 29(3):1877-80. PubMed ID: 9142310
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolytic modulation of factor Xa-antithrombin complex enhances fibrinolysis in plasma.
    Talbot K; Meixner SC; Pryzdial EL
    Biochim Biophys Acta; 2013 Jun; 1834(6):989-95. PubMed ID: 23416531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.